Risk model based on MRI fusion biopsy characteristics predicts biochemical recurrence after radical prostatectomy. Chen Z, Wu J, Sun K, He Y, et al. Prostate 2022;82:566-575.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen Z, Wu J, Sun K, He Y, et al. Risk model based on MRI fusion biopsy characteristics predicts biochemical recurrence after radical prostatectomy. Prostate 2022;82:566-575.
PMID: 35067945